FARALLON CAPITAL MANAGEMENT LLC Q4 2020 Filing
Filed February 16, 2021
Portfolio Value
$15.4B
Holdings
131
Report Date
Q4 2020
Filing Type
13F-HR
All Holdings (131 positions)
| Stock | Value |
|---|---|
IQVIQVIA HLDGS INC | $724.5B |
GOOGALPHABET INC | $632.6B |
TMUST-MOBILE US INC | $532.5B |
TMOTHERMO FISHER SCIENTIFIC INC | $519.0B |
SPYSPDR S&P 500 ETF TR | $510.3B |
VVISA INC | $487.4B |
AONAON PLC | $479.9B |
BSXBOSTON SCIENTIFIC CORP | $475.9B |
FISFIDELITY NATL INFORMATION SV | $445.5B |
ARMKARAMARK | $424.2B |
CNCCENTENE CORP DEL | $411.2B |
ELVANTHEM INC | $409.4B |
MSFTMICROSOFT CORP | $391.1B |
WABWABTEC | $365.8B |
CHTRCHARTER COMMUNICATIONS INC N | $361.8B |
NYTNEW YORK TIMES CO | $338.9B |
XLRNACCELERON PHARMA INC | $332.6B |
RTXRAYTHEON TECHNOLOGIES CORP | $324.8B |
METAFACEBOOK INC | $315.2B |
CRMSALESFORCE COM INC | $313.6B |
TIFEURTIFFANY & CO NEW | $300.6B |
SHWSHERWIN WILLIAMS CO | $286.1B |
IOVAIOVANCE BIOTHERAPEUTICS INC | $278.4B |
FATEFATE THERAPEUTICS INC | $272.8B |
AVGOBROADCOM INC | $272.8B |
BXBLACKSTONE GROUP INC | $252.2B |
EX9EXELIXIS INC | $220.8B |
EDUNEW ORIENTAL ED & TECHNOLOGY | $214.5B |
WTWWILLIS TOWERS WATSON PLC LTD | $202.8B |
BABAALIBABA GROUP HLDG LTD | $198.6B |
MRTXEURMIRATI THERAPEUTICS INC | $192.2B |
HLTHILTON WORLDWIDE HLDGS INC | $182.5B |
—QIAGEN NV | $172.1B |
TRUTRANSUNION | $172.1B |
ASNDASCENDIS PHARMA A/S | $166.8B |
HWMHOWMET AEROSPACE INC | $139.6B |
APLSAPELLIS PHARMACEUTICALS INC | $130.1B |
ABBVABBVIE INC | $123.2B |
AMRSEURAMYRIS INC | $108.1B |
SRPTSAREPTA THERAPEUTICS INC | $102.3B |
MOMO 1.25 07/01/25MOMO INC | $93.5B |
PCGPG&E CORP | $90.9B |
SG7SAGE THERAPEUTICS INC | $90.8B |
PLYAPLAYA HOTELS & RESORTS NV | $89.2B |
LULUFAX HOLDING LTD | $76.1B |
ENTAENANTA PHARMACEUTICALS INC | $74.7B |
—BROADMARK RLTY CAP INC | $73.1B |
KSUEURKANSAS CITY SOUTHERN | $72.3B |
IQ 2 04/01/25IQIYI INC | $71.8B |
EFXEQUIFAX INC | $71.5B |
KRTXKARUNA THERAPEUTICS INC | $71.1B |
FGENEURFIBROGEN INC | $70.5B |
BCABBIOATLA INC | $66.9B |
GBIOGBXGENERATION BIO CO | $64.3B |
ARNAEURARENA PHARMACEUTICALS INC | $57.6B |
PACBPACIFIC BIOSCIENCES CALIF IN | $54.5B |
—THERAVANCE BIOPHARMA INC | $53.8B |
CYTKCYTOKINETICS INC | $49.9B |
PTGXPROTAGONIST THERAPEUTICS INC | $48.9B |
ALNYALNYLAM PHARMACEUTICALS INC | $45.5B |
—ZOGENIX INC | $45.0B |
CLGXCORELOGIC INC | $44.4B |
KPTI 3 10/15/25KARYOPHARM THERAPEUTICS INC | $43.5B |
AGIOAGIOS PHARMACEUTICALS INC | $43.3B |
ISIIONIS PHARMACEUTICALS INC | $42.4B |
ANNXANNEXON INC | $39.0B |
—RADIUS HEALTH INC | $37.6B |
CARAEURCARA THERAPEUTICS INC | $37.3B |
INSM 1.75 01/15/25INSMED INC | $36.6B |
CLVS 1.25 05/01/25CLOVIS ONCOLOGY INC | $36.1B |
LNTHLANTHEUS HLDGS INC | $35.7B |
—ZYMEWORKS INC | $35.4B |
KRYSKRYSTAL BIOTECH INC | $31.5B |
NVV1NOVAVAX INC | $30.7B |
—IQIYI INC | $29.9B |
—PANACEA ACQUISITION CORP | $29.3B |
AM6AMICUS THERAPEUTICS INC | $28.9B |
—CLEVER LEAVES HOLDINGS INC | $28.7B |
DMTKQDERMTECH INC | $27.9B |
BIIBBIOGEN INC | $25.2B |
—CONSTELLATION PHARMCETICLS I | $21.6B |
BEKEKE HLDGS INC | $21.1B |
GRFSGRIFOLS S A | $20.6B |
IQ 4 12/15/26IQIYI INC | $20.0B |
—ZEALAND PHARMA A/S | $18.3B |
—ATENTO S A | $18.2B |
PLRXPLIANT THERAPEUTICS INC | $17.4B |
DCPHEURDECIPHERA PHARMACEUTICALS IN | $17.1B |
INBXUSDINHIBRX INC | $16.8B |
RCREADY CAPITAL CORP | $16.8B |
ADVMCHFADVERUM BIOTECHNOLOGIES INC | $16.3B |
BMYBRISTOL-MYERS SQUIBB CO | $15.5B |
BMY-RBRISTOL-MYERS SQUIBB CO | $14.8B |
PRAXPRAXIS PRECISION MEDICINES I | $13.8B |
XPOXPO LOGISTICS INC | $13.1B |
—NUANCE COMMUNICATIONS INC | $13.1B |
NTLAINTELLIA THERAPEUTICS INC | $12.2B |
—TIGA ACQUISITION CORP | $11.4B |
—AVROBIO INC | $11.1B |
RCKTROCKET PHARMACEUTICALS INC | $11.0B |
Page 1 of 2Next